Passage Bio Stock Investor Sentiment
| PASG Stock | USD 8.28 0.33 4.15% |
Roughly 55% of Passage Bio's stockholders are presently thinking to get in. The analysis of the overall investor sentiment regarding Passage Bio suggests that some traders are interested. The current market sentiment, together with Passage Bio's historical and current headlines, can help investors time the market. In addition, many technical investors use Passage Bio stock news signals to limit their universe of possible portfolio assets.
Comfort Level 55
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Passage Bio's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Passage Bio.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
Passage Historical Sentiment
Although Passage Bio's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Passage, such as negative comments on social media and news outlets, may cause fear in the market and push Passage Bio's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Passage.
Passage Bio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Passage Bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Passage Bio's Stock prices. Below is the latest headlines and news related to Passage Bio Stock. Current markets are slightly bullish. About 57% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Passage Bio that are available to investors today. This information is accessible both publicly - through Passage Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Passage-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Passage Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Passage Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Passage Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Passage Bio alpha.
Passage Largest EPS Surprises
Earnings surprises can significantly impact Passage Bio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-05-12 | 2025-03-31 | -0.2233 | -0.25 | -0.0267 | 11 | ||
2024-08-08 | 2024-06-30 | -0.31 | -0.26 | 0.05 | 16 | ||
2024-05-14 | 2024-03-31 | -0.36 | -0.3 | 0.06 | 16 | ||
2024-03-04 | 2023-12-31 | -0.4 | -0.3 | 0.1 | 25 | ||
2022-08-04 | 2022-06-30 | -0.83 | -0.73 | 0.1 | 12 | ||
2022-05-16 | 2022-03-31 | -0.89 | -0.79 | 0.1 | 11 |
There is far too much social signal, news, headlines, and media speculation about Passage Bio that are available to investors today. This information is accessible both publicly - through Passage Bio's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Passage-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Passage Bio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Passage Bio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Passage Bio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Passage Bio alpha.
Passage Bio Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by Lynx1 Capital Management Lp of 13123 shares of Passage Bio at 5.4361 subject to Rule 16b-3 | 07/22/2025 |
2 | Acquisition by Lynx1 Capital Management Lp of 66423 shares of Passage Bio at 5.7127 subject to Rule 16b-3 | 07/24/2025 |
3 | Canaccord Genuity lowers Passage Bio stock price target to 67 from 260 - Investing.com | 08/14/2025 |
4 | Recovery Setup Building in Passage Bio Inc. Experts Say - 2025 Volume Leaders Safe Entry Trade Signal Reports - thegnnews.com | 08/19/2025 |
5 | How high can Passage Bio Inc. stock go - Trade Ideas Technical Pattern Based Signals - Newser | 08/27/2025 |
6 | Real time pattern detection on Passage Bio Inc. stock - July 2025 PreEarnings Real-Time Volume Trigger Notifications - Newser | 09/02/2025 |
7 | Passage Bio Raised to Hold at Wall Street Zen | 09/08/2025 |
8 | Acquisition by Lynx1 Capital Management Lp of 325 shares of Passage Bio at 6.9558 subject to Rule 16b-3 | 09/11/2025 |
9 | Acquisition by Lynx1 Capital Management Lp of 19783 shares of Passage Bio at 6.9908 subject to Rule 16b-3 | 09/12/2025 |
10 | How does Passage Bio Inc perform in inflationary periods - Market Rally Fast Exit and Entry Trade Guides - | 09/18/2025 |
11 | Passage Bio, Inc. Receives 75.67 Consensus Price Target from Brokerages | 10/08/2025 |
Complementary Tools for Passage Stock analysis
When running Passage Bio's price analysis, check to measure Passage Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Passage Bio is operating at the current time. Most of Passage Bio's value examination focuses on studying past and present price action to predict the probability of Passage Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Passage Bio's price. Additionally, you may evaluate how the addition of Passage Bio to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |